EFFICACY OF INDACATEROL, A MODERN ULTRALONG-ACTING
BRONCHODILATOR, IN ELDERLY PATIENTS WITH CHRONIC
OBSTRUCTIVE PULMONARY DISEASE
SORIN BERBECARU–IOVAN1, ANCA BERBECARU–IOVAN2*, ELENA CAMELIA
STĂNCIULESCU2, IULIANA CEAUŞU3, GABRIELA RĂU2, CĂTĂLINA GABRIELA PISOSCHI2
1Faculty of Medicine, University of Medicine and Pharmacy, 2 Petru Rareş, 200349, Craiova, Romania,
2Faculty of Pharmacy, University of Medicine and Pharmacy, 2 Petru Rareş, 200349, Craiova, Romania,
3Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, Dr. Ion Cantacuzino Hospital, 5-7 Ion Movilă,
Bucharest, Romania
*corresponding author: ancaberbecaru@yahoo.com
Download Full Article

Abstract:
Chronic obstructive pulmonary disease (COPD) is one of the most prevalent chronic diseases among elderly population
worldwide. Because of the central role of long-acting bronchodilators in the treatment of COPD, the interest of researchers
for the development of new bronchodilators agents administered in a single dose is increasing in order to simplify the
regimen for patients with moderate to severe COPD and to improve patient adherence to treatment...

Top